F. Radaelli et al., Factors predicting response to splenectomy in adult patients with idiopathic thrombocytopenic purpura, HAEMATOLOG, 85(10), 2000, pp. 1040-1044
Background and Objectives. Splenectomy is the treatment of choice in the ma
jority of patients affected by idiopathic thrombocytopenic purpura refracto
ry to corticosteroid therapy, but it is not free from early and late compli
cations. As the available literature does not seem to contain any precise i
ndications concerning possible factors predicting the response to splenecto
my, the aim of this retrospective study of 65 splenectomized patients was t
o attempt to identify potentially predictive clinical or laboratory paramet
ers.
Design and Methods. For the purposes of statistical analysis, the patients
were divided into two groups: the first included those with a complete (pla
telets > 100x10(9)/L) or partial response (platelets 50-100 x10(9)/L) to sp
lenectomy; the second, the non-responders (platelets < 50x10(9)/L). The non
-parametric tests were based on the Kruskal-Wallis method for independent s
amples, and the independent samples were compared using the Chi-square test
according to Pearson.
Results. Univariate analysis did not reveal any significant correlation bet
ween successful splenectomy and age, sex, platelet count at diagnosis, anti
,platelets antibody positivity, the site of platelet :sequestration, the ti
me between diagnosis and surgery, or the response to high intravenous immun
oglobulin doses. However, the probability of success was greater in the pat
ients with a complete or partial pre-operative response to steroid therapy
(p<0.05).
Interpretation and Conclusions. The factor most frequently associated with
the success of splenectomy is the site of autologous platelet sequestration
. Our study did not identify any clinical or laboratory parameter clearly p
redictive of post-splenectomy cure other than a transient response to stero
id treatment. this finding needs further confirmation in larger patient pop
ulations. (C)2000, Ferrata Storti Foundation.